Rare Lung Disease Research
نویسندگان
چکیده
منابع مشابه
Pleuroparenchymal fibroelastosis: a rare interstitial lung disease
Pleuroparenchymal fibroelastosis (PPFE) is a newly described form of interstitial lung disease that originates in the upper lung zones and typically progresses to involve the entire lung. The disease may be idiopathic but is often associated with other pre- or coexisting conditions. Pneumothorax is a common complication and can occur at presentation or at other times during the course of the di...
متن کاملA Rare Tonsillar Disease
A 16 year old women with Tangier disease in palatine tonsils is reported. She has recurrent sore throat. In physical examination the palatine tonsils are hypertrophied and has very yellowish points. The facial skin is yellowish the skin of another areas of body is normal. After tonsillectomy the pathologist report Tangier disease in palatine tonsils.
متن کاملburden of obstructive lung disease study in tehran: research design and lung spirometry protocol
background: chronic obstructive pulmonary diseases (copd) are planned to rank fifth in burden of disease and third with respect to mortality by 2020. carrying out research regarding different aspects of copd is mentioned as important health priorities by academic institutions and governments. the burden of lung disease (bold) initiative was designed a decade ago to develop robust models that ca...
متن کاملRare disease research: Breaking the privacy barrier
Due to the few patients affected, rare disease research has to count on international registries to exist in order to produce significant research outputs. Data sharing of registries is therefore a unique resource to allow rare disease research to flourish and any lost data will jeopardize the quality of an already extremely difficult research. The rules usually applied to research such as the ...
متن کاملCollaboration for rare disease drug discovery research
Rare disease research has reached a tipping point, with the confluence of scientific and technologic developments that if appropriately harnessed, could lead to key breakthroughs and treatments for this set of devastating disorders. Industry-wide trends have revealed that the traditional drug discovery research and development (R&D) model is no longer viable, and drug companies are evolving the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2019
ISSN: 0012-3692
DOI: 10.1016/j.chest.2019.05.004